Traditional recruitment methods are not keeping pace with demand, nor are they providing the diversity of participants required by research.
November 06, 2020
The world is waiting with great anticipation as clinical trials are being conducted for COVID-19. Recruitment challenges are nothing new for study teams, but for sponsors conducting COVID-19 trials, they are magnified under the watchful eyes of the world.
In this webinar, TrialScope will pull back the curtain on a novel approach to clinical trial recruitment, revealing how one sponsor embraced a new technology platform that enabled it to flip the recruitment funnel to accelerate patient referrals, fill diversity gaps and reduce site and patient burden.
Traditional recruitment methods are not keeping pace with demand, nor are they providing the diversity of participants required by research. We will share why this new, alternative approach – using data, innovative referral & pre-screening technology and activating multiple recruitment partners simultaneously – was the answer.
Join TrialScope’s Mike Wenger, Vice President of Patient Engagement, and Christina Masturzo, Director of Product Management, in a live webinar on Thursday, November 19, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Unmasking How a COVID-19 Trial Team Expedited Recruitment, Filled Diversity Gaps and Reduced Site Burden Using Technology.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Share article on social media or email: